KCTD1
protein-codingpotassium channel tetramerization domain containing 1, the group of MicroRNA protein coding host genes|KCTD family
Gene summary
This gene encodes a protein containing a BTB (Broad-complex, tramtrack and bric a brac), also known as a POZ (POxvirus and zinc finger) protein-protein interaction domain. The encoded protein negatively regulates the AP-2 family of transcription factors and the Wnt signaling pathway. A mechanism for the modulation of Wnt signaling has been proposed in which the encoded protein enhances ubiquitination and degradation of the beta-catenin protein. Mutations in this gene have been identified in Scalp-ear-nipple (SEN) syndrome. [provided by RefSeq, May 2017]
- C18orf5
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~202.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008404
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0008404
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0008404
Submitter: ClinGen
The *KCTD1* (potassium channel tetramerization domain containing 1) gene is located on chromosome 18 at 18q11.2 and encodes a protein containing a BTB (Broad-complex, tramtrack and bric a brac) protein-protein interaction domain. This protein negatively regulates the AP-2 family of transcription factors and the Wnt signaling pathway. Variants in this gene are associated with Scalp-Ear-Nipple (SEN) syndrome, a rare genetic disorder characterized by defects in the scalp, malformed ears, and absent/hypoplastic nipples. *KCTD1* was first reported in connection with SEN syndrome in 2013 (Marneros et al., 2013, PMID: 23541344). Evidence supporting this gene-disease relationship includes case-level data and experimental data. Thirteen variants (12 missense, 1 inframe insertion) reported in 13 probands across five publications have been included in this curation (PMIDs: 8042668; 23541344; 39424163; 33883917; 34456244). The mechanism of pathogenicity is loss-of-function. This gene-disease relationship is also supported by experimental evidence including biochemical function, protein interaction, and model organism data). GST pull-down assays demonstrated *KCTD1* and transcription factor AP-2α interact directly in vitro (PMID: 191153150). Variants in TFAP2A cause Branchio-Oculo-Facial syndrome, which presents with clinical characteristics that overlap with those found in individuals with *KCTD1* variants. *KCTD1* and AP-2α overexpression is shown to decrease β-catenin expression levels (PMID:33000225). The canonical Wnt/β-catenin pathway is one of the downstream regulated pathways of *KCTD1*, and it serves a crucial role in ectoderm patterning and craniofacial development. KCDT1 WT is also required for cell cell viability of keratinocytes (PMID: 38113115). Inactivation of Kctd1 in the kidney (Six2Cre+Kctd1fl/fl mice) results in a terminal differentiation defect in the distal convoluted tubule (DCT) that impairs renal function and leads to a severe interstitial renal fibrosis in the adult with aging, similarly as seen in SEN syndrome patients (PMID: 38113115). In summary, there is definitive evidence supporting the relationship between *KCTD1* and autosomal dominant SEN syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date June 4, 2025 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0008404
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0008404
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KCTD1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001142730.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 26 | 1 | 28 | ||
| missense | 9 | 4 | 142 | 9 | 1 | 165 |
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 9 | 4 | 146 | 35 | 2 | 196 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001136202.1 | 5 | MANE Select | |
| Ensembl | ENSP00000463041.2 | 5 | MANE Select | |
| RefSeq | NP_001129677.1 | 4 | Standard | |
| RefSeq | NP_001245150.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gene expression (Transcription)
- Generic Transcription Pathway
- RNA Polymerase II Transcription
- Negative regulation of activity of TFAP2 (AP-2) family transcription factors
- Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
Biological Process
- negative regulation of transcription by RNA polymerase II
- negative regulation of transcription, DNA-templated
- protein homooligomerization
Molecular Function
- transcription corepressor activity
- protein binding
- transcription factor binding
- identical protein binding
Cellular Component
- nucleus
- nucleoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000408011
- Coding exons
- 4
- Length
- 202492
- Individuals with no LoFs
- 125730
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 2
- Defined
- 125732
- p
- 0.00000795
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.82 | 95 | 160 | 0.594 | 0.00000988 | 1671 |
| Missense (PolyPhen) | 15 | 45.413 | 0.3303 | 560 | ||
| Synonymous | 1.19 | 54 | 66.3 | 0.815 | 0.00000459 | 513 |
| Loss of Function | 2.75 | 1 | 10.7 | 0.0933 | 5.17e-7 | 131 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000030 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May repress the transcriptional activity of AP-2 family members, including TFAP2A, TFAP2B and TFAP2C to various extent. {ECO:0000269|PubMed:18358072, ECO:0000269|PubMed:19115315}.;
- Disease
- DISEASE: Scalp-ear-nipple syndrome (SENS) [MIM:181270]: A disease characterized by aplasia cutis congenita of the scalp, breast anomalies that range from hypothelia or athelia to amastia, and minor anomalies of the external ears. Less frequent clinical characteristics include nail dystrophy, dental anomalies, cutaneous syndactyly of the digits, and renal malformations. Penetrance appears to be high, although there is substantial variable expressivity within families. {ECO:0000269|PubMed:23541344}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- LoFtool
- 0.0836
- RVIS EVS
- -0.41
- RVIS percentile EVS
- 26.23
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.148
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |